A new model of the metabolic fate of ganolidin has been developed.
This new model can be used to study its role in the metabolism of granular materials, and the effects of dietary supplements on its synthesis.
The mechanism for its action is well known: a small amount of the ingested material stimulates the synthesis and breakdown of granules in a cell.
However, this is not the case for granulocytes.
The present model has been designed to allow the simultaneous measurement of both the formation of granule-like structures as well as their metabolism.
It is now possible to use this model to study granulocyte-derived polysaccharides (GDP), a class of polysacchylcholine-derived molecules that have been shown to have potential anti-inflammatory and antioxidant activities.